Silo Pharma extends stock repurchase program up to $1M through March 31, 2024

Silo Pharma, Inc.

Board extended stock repurchase program through March 31, 2024.
Authorization remains at up to $1 million of common stock.
Extension approved on January 9, 2024.

item 8.01 item 9.01

Silo Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-002314

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.